Proceedings (Mar 2024)
Evaluation of the Safety of Folate Receptor-Targeted Boron Carrier in Boron Neutron Capture Therapy (BNCT) for Malignant Gliomas Using CED Administration
- Kohei Tsujino,
- Hideki Kashiwagi,
- Ryo Kayama,
- Yoshiki Fujikawa,
- Yusuke Fukuo,
- Ryo Hiramatsu,
- Naosuke Nonoguchi,
- Takushi Takata,
- Hiroki Tanaka,
- Minoru Suzuki,
- Naonori Hu,
- Masahiko Wanibuchi,
- Kei Nakai,
- Kai Nishimura,
- Hiroyuki Nakamura,
- Shinji Kawabata
Affiliations
- Kohei Tsujino
- Department of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Japan
- Hideki Kashiwagi
- Department of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Japan
- Ryo Kayama
- Department of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Japan
- Yoshiki Fujikawa
- Department of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Japan
- Yusuke Fukuo
- Department of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Japan
- Ryo Hiramatsu
- Department of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Japan
- Naosuke Nonoguchi
- Department of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Japan
- Takushi Takata
- Institute for Integrated Radiation and Nuclear Science, Kyoto University, Kumatori 520-2113, Japan
- Hiroki Tanaka
- Institute for Integrated Radiation and Nuclear Science, Kyoto University, Kumatori 520-2113, Japan
- Minoru Suzuki
- Institute for Integrated Radiation and Nuclear Science, Kyoto University, Kumatori 520-2113, Japan
- Naonori Hu
- Kansai BNCT Medical Center, Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Japan
- Masahiko Wanibuchi
- Department of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Japan
- Kei Nakai
- Department of Radiation Oncology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan
- Kai Nishimura
- Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, Yokohama 226-8503, Japan
- Hiroyuki Nakamura
- Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, Yokohama 226-8503, Japan
- Shinji Kawabata
- Department of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Japan
- DOI
- https://doi.org/10.3390/proceedings2024100015
- Journal volume & issue
-
Vol. 100,
no. 1
p. 15
Abstract
Knowing how to accumulate boron into the tumor cells is a crucial aspect of boron neutron capture therapy (BNCT), which can be targeted at the cellular level, and the development of novel boron agents other than BPA, which is used in clinical practice, is urgently needed [...]
Keywords
